Forget this whole “election” charade and just glue the crown onto her head, already.
Ursula von der Leyen, the unelected European Commission President, is up for job renewal in June. She’d have to be re-nominated by the majority of EU member state leaders and then re-confirmed by members of the newly-elected European Parliament. They’d have to be crazy to dethrone this ultimate incarnation of true EU values, like transparency and foresight (or rather, lack thereof).
One particular tale about Queen Ursula comes to mind that perfectly illustrates the point.
During Covid, the European Union rolled out a bloc-wide QR code system as proof of vaccination for travel, leisure, and in some cases a condition of employment – even as reports started raising doubts about how reliable the shot really was when it came to stopping infection, transmission, and death. It’s like there was this interest in Brussels to move fast in getting shots into arms as quickly as possible, and setting up this digital identity system linked to jab status before the scary music stopped or people just tuned it out. Skeptical members of the European Parliament have been demanding to know what kind of deal the bloc’s leadership actually signed with the manufacturers of these injections. We’re talking about 11 contracts, 4.6 billion vaccines, and €71 billion of public money transferred to Big Pharma.
So far, neither the citizens who paid for all of it, nor their elected representatives have been able to get full transparency on those deals. According to research published last year by the French NGO Global Health Advocates, and the UK based health nonprofit, StopAids, the European Commission “agreed to extensive confidentiality requirements with pharmaceutical corporations that may not be fully consistent with EU legislation,” and that of the contracts analyzed with AstraZeneca,........